Remediation of a mixture of analgesics in a stirred-tank photobioreactor using microalgal-bacterial consortium coupled with attempt to valorise the harvested biomass

Algae-Mediated Removal of Prevalent Genotoxic Antibiotics: Molecular Perspective on Algae-Bacteria Consortia and Bioreactor-Based Strategies

Antibiotic pollution poses a potential risk of genotoxicity, as antibiotics released into the environment can induce DNA damage and mutagenesis in various organisms. This pollution, stemming from pharmaceutical manufacturing, agriculture, and improper disposal, can disrupt aquatic ecosystems and potentially impact human health through the consumption of contaminated water and food. The removal of genotoxic antibiotics using algae-mediated approaches has gained considerable attention due to its potential for mitigating the environmental and health risks associated with these compounds. The paper provides an in-depth examination of the molecular aspects concerning algae and bioreactor-driven methodologies utilized for the elimination of deleterious antibiotics. The molecular analysis encompasses diverse facets, encompassing the discernment and profiling of algae species proficient in antibiotic degradation, the explication of enzymatic degradation pathways, and the refinement of bioreactor configurations to augment removal efficacy. Emphasizing the significance of investigating algal approaches for mitigating antibiotic pollution, this paper underscores their potential as a sustainable solution, safeguarding both the environment and human health.

Microalgal-based bioremediation of emerging contaminants: Mechanisms and challenges

Emerging contaminants (ECs) in different ecosystems have consistently been acknowledged as a global issue due to toxicity, human health implications, and potential role in generating and disseminating antimicrobial resistance. The existing wastewater treatment system is incompetent at eliminating ECs since the effluent water contains significant concentrations of ECs, viz., antibiotics (0.03-13.0 μg L-1), paracetamol (50 μg L-1), and many others in varying concentrations. Microalgae are considered as a prospective and sustainable candidate for mitigating of ECs owing to some peculiar features. In addition, the microalgal-based processes also offer cost and energy-efficient solutions for the bioremediation of ECs than conventional treatment systems. It is pertinent that, microalgal-based processes also provides waste valorization benefits as microalgal biomass obtained after ECs treatment can be potentially applied to generate biofuels. Moreover, microalgae can effectively utilize alternative metabolic (cometabolism) routes for enhanced degradation of ECs. Additionally, the ECs removal via the microalgal biodegradation route is highly promising as it can transform the ECs into less toxic compounds. The present review comprehensively discusses different mechanisms involved in removing ECs and various factors that affect their removal. Also, the technoeconomic feasibility of microalgae than other conventional wastewater treatment methods is summarised. The review also highlighted the different molecular and genetic tools that can augment the activity and robustness of microalgae for better removal of organic contaminants. Finally, we have summarised the challenges and future research required towards microalgal-based bioremediation of emerging contaminants (ECs) as a holistic approach.

Removal of organic and inorganic contaminants from the air, soil, and water by algae

Rapid increases in human populations and development has led to a significant exploitation of natural resources around the world. On the other hand, humans have come to terms with the consequences of their past mistakes and started to address current and future resource utilization challenges. Today's primary challenge is figuring out and implementing eco-friendly, inexpensive, and innovative solutions for conservation issues such as environmental pollution, carbon neutrality, and manufacturing effluent/wastewater treatment, along with xenobiotic contamination of the natural ecosystem. One of the most promising approaches to reduce the environmental contamination load is the utilization of algae for bioremediation. Owing to their significant biosorption capacity to deactivate hazardous chemicals, macro-/microalgae are among the primary microorganisms that can be utilized for phytoremediation as a safe method for curtailing environmental pollution. In recent years, the use of algae to overcome environmental problems has advanced technologically, such as through synthetic biology and high-throughput phenomics, which is increasing the likelihood of attaining sustainability. As the research progresses, there is a promise for a greener future and the preservation of healthy ecosystems by using algae. They might act as a valuable tool in creating new products.

Ketoprofen as an emerging contaminant: occurrence, ecotoxicity and (bio)removal

Ketoprofen, a bicyclic non-steroidal anti-inflammatory drug commonly used in human and veterinary medicine, has recently been cited as an environmental contaminant that raises concerns for ecological well-being. It poses a growing threat due to its racemic mixture, enantiomers, and transformation products, which have ecotoxicological effects on various organisms, including invertebrates, vertebrates, plants, and microorganisms. Furthermore, ketoprofen is bioaccumulated and biomagnified throughout the food chain, threatening the ecosystem function. Surprisingly, despite these concerns, ketoprofen is not currently considered a priority substance. While targeted eco-pharmacovigilance for ketoprofen has been proposed, data on ketoprofen as a pharmaceutical contaminant are limited and incomplete. This review aims to provide a comprehensive summary of the most recent findings (from 2017 to March 2023) regarding the global distribution of ketoprofen in the environment, its ecotoxicity towards aquatic animals and plants, and available removal methods. Special emphasis is placed on understanding how ketoprofen affects microorganisms that play a pivotal role in Earth's ecosystems. The review broadly covers various approaches to ketoprofen biodegradation, including whole-cell fungal and bacterial systems as well as enzyme biocatalysts. Additionally, it explores the potential of adsorption by algae and phytoremediation for removing ketoprofen. This review will be of interest to a wide range of readers, including ecologists, microbiologists, policymakers, and those concerned about pharmaceutical pollution.

Trends in microalgal-based systems as a promising concept for emerging contaminants and mineral salt recovery from municipal wastewater

In the context of climate change leading to water scarcity for many people in the world, the treatment of municipal wastewater becomes a necessity. However, the reuse of this water requires secondary and tertiary treatment processes to reduce or eliminate a load of dissolved organic matter and various emerging contaminants. Microalgae have shown hitherto high potential applications of wastewater bioremediation thanks to their ecological plasticity and ability to remediate several pollutants and exhaust gases from industrial processes. However, this requires appropriate cultivation systems allowing their integration into wastewater treatment plants at appropriate insertion costs. This review aims to present different open and closed systems currently used in the treatment of municipal wastewater by microalgae. It provides an exhaustive approach to wastewater treatment systems using microalgae, integrating the most suitable used microalgae species and the main pollutants present in the treatment plants, with an emphasis on emerging contaminants. The remediation mechanisms as well as the capacity to sequester exhaust gases were also described. The review examines constraints and future perspectives of microalgae cultivation systems in this line of research.

Removal of parabens from wastewater by Chlorella vulgaris-bacteria co-cultures

Anthropogenic activities have increased the dispersal of emerging contaminants (ECs), particularly of parabens, causing an escalation of their presence in wastewater (WW). Current WW technologies do not present satisfactory efficiency or sustainability in removing these contaminants. However, bioremediation with microalgae-based systems is proving to be a relevant technology for WW polishing, and the use of microalgae-bacteria consortia can improve the efficiency of WW treatment. This work aimed to study dual cultures of selected bacteria (Raoultella ornithinolytica, Acidovorax facilis, Acinetobacter calcoaceticus, Leucobacter sp. or Rhodococcus fascians) and the microalga Chlorella vulgaris in microbial growth and WW bioremediation - removal of methylparaben (MetP) and nutrients. The association with the bacteria was antagonistic for C. vulgaris biomass productivity as a result of the decreased growth kinetics in comparison to the axenic microalga. The presence of MetP did not disturb the growth of C. vulgaris under axenic or co-cultured conditions, except when associated with R. fascians, where growth enhancement was observed. The removal of MetP by the microalga was modest (circa 30 %, with a removal rate of 0.0343 mg/L.d), but increased remarkably when the consortia were used (> 50 %, with an average removal rate > 0.0779 mg/L.d), through biodegradation and photodegradation. For nutrient removal, the consortia were found to be less effective than the axenic microalga, except for nitrogen (N) removal by C. vulgaris w/ R. fascians. The overall results propose that C. vulgaris co-cultivation with bacteria can increase MetP removal, while negatively affecting the microalga growth and the consequent reduction of sludge production, highlighting the potential of microalgae-bacteria consortia for the effective polishing of WW contaminated with parabens.

Pharmaceuticals in the Aquatic Environment: A Review on Eco-Toxicology and the Remediation Potential of Algae

The pollution of the aquatic environment has become a worldwide problem. The widespread use of pesticides, heavy metals and pharmaceuticals through anthropogenic activities has increased the emission of such contaminants into wastewater. Pharmaceuticals constitute a significant class of aquatic contaminants and can seriously threaten the health of non-target organisms. No strict legal regulations on the consumption and release of pharmaceuticals into water bodies have been implemented on a global scale. Different conventional wastewater treatments are not well-designed to remove emerging contaminants from wastewater with high efficiency. Therefore, particular attention has been paid to the phycoremediation technique, which seems to be a promising choice as a low-cost and environment-friendly wastewater treatment. This technique uses macro- or micro-algae for the removal or biotransformation of pollutants and is constantly being developed to cope with the issue of wastewater contamination. The aims of this review are: (i) to examine the occurrence of pharmaceuticals in water, and their toxicity on non-target organisms and to describe the inefficient conventional wastewater treatments; (ii) present cost-efficient algal-based techniques of contamination removal; (iii) to characterize types of algae cultivation systems; and (iv) to describe the challenges and advantages of phycoremediation.

Biodegradation of pharmaceuticals in photobioreactors - a systematic literature review

This work is a systematic review that reports state-of-the-art in removal of pharmaceuticals from water and wastewater by photosynthetic organisms in photobioreactors. The PRISMA protocol-based review of the most recent literature data from the last 10 years (2011–2021) was reported. Articles were searched by the combination of the following keywords: photobioreactor, pharmaceuticals, drugs, hormones, antibiotics, biodegradation, removal, wastewater treatment. The review focuses on original research papers (not reviews), collected in 3 scientific databases: Scopus, Web of Knowledge, PubMed. The review considered the following factors: type of microorganisms, type of micropollutants removed, degradation efficiency and associated products, types of photosynthetic organisms and photobioreactor types. The conclusion from the systematic review is that the main factors that limit widespread pharmaceuticals removal in photobioreactors are high costs and the problem of low efficiency related with low concentrations of pharmaceuticals. The review indicated a need for further research in this area due to increasing amounts of metabolites in the food chain, such as p-aminophenol and estrone, which can cause harm to people and ichthyofauna. Pharmaceuticals removal can be improved by adapting the type of microorganism used to the type of contamination and implementing photoperiods, which increase the removal efficiency of e.g. sulfamethazine by up to 28%. In the future, it is necessary to search for new solutions in terms of the construction of photobioreactors, as well as for more effective species in terms of pharmaceuticals biodegradation that can survive the competition with other strains during water and wastewater treatment.

Microalgal-based removal of contaminants of emerging concern

The presence of contaminants of emerging concern (CECs) in the environment has been recognized as a worldwide concern. In particular, water pollution by CECs is becoming a major global problem, which requires ongoing evaluation of water resources policies at all levels and the use of effective and innovative wastewaters treatment processes for their removal. Microalgae have been increasingly recognized as relevant for wastewater polishing, including CECs removal. These microorganisms are commonly cultivated in suspension. However, the use of planktonic microalgae for wastewater treatment has limitations in terms of microbiological contamination, process effectiveness and sustainability. The use of consortia of microalgae and bacteria represents a significant advance for sustainable wastewater polishing, particularly when the microorganisms are associated as biofilms. These immobilized mixed cultures can overcome the limitations of suspended-microalgae systems and improve the performance of the involved species for CECs removal. In addition, microalgae-bacteria based systems can offer a relevant combined effect for CECs removal and biomass production enhancement. This study reviews the advantages and advances on the use of microalgae for wastewater treatment, highlighting the potential on the use of microalgae-bacteria biofilms for CECs removal and the further biomass valorisation for third-generation biofuel production.

Pharmaceuticals and personal care products in aquatic environments and their removal by algae-based systems

The consumption of pharmaceuticals and personal care products (PPCPs) has been widely increasing, yet up to 90-95% of PPCPs consumed by human are excreted unmetabolized. Moreover, the most of PPCPs cannot be fully removed by wastewater treatment plants (WWTPs), which release PPCPs to natural water bodies, affecting aquatic ecosystems and potentially humans. This study sought to review the occurrence of PPCPs in natural water bodies globally, and assess the effects of important factors on the fluxes of pollutants into receiving waterways. The highest ibuprofen concentration (3738 ng/L) in tap water was reported in Nigeria, and the highest naproxen concentration (37,700 ng/L) was reported in groundwater wells in Penn State, USA. Moreover, the PPCPs have affected aquatic organisms such as fish. For instance, up to 24.4 × 10³ ng/g of atenolol was detected in P. lineatus. Amongst different technologies to eliminate PPCPs, algae-based systems are environmentally friendly and effective because of the photosynthetic ability of algae to absorb CO₂ and their flexibility to grow in different wastewater. Up to 99% of triclosan and less than 10% of trimethoprim were removed by Nannochloris sp., green algae. Moreover, variable concentrations of PPCPs might adversely affect the growth and production of algae. The exposure of algae to high concentrations of PPCPs can reduce the content of chlorophyll and protein due to producing reactive oxygen species (ROS), and affecting expression of some genes in chlorophyll (rbcL, psbA, psaB and psbc).

Phycoremediation integrated approach for the removal of pharmaceuticals and personal care products from wastewater - A review

Pharmaceuticals and personal care products (PPCPs) are of emerging concerns because of their large usage, persistent nature which promised their continuous disposal into the environment, as these pollutants are stable enough to pass through wastewater treatment plants causing hazardous effects on all the organisms through bioaccumulation, biomagnification, and bioconcentration. The available technologies are not capable of eliminating all the PPCPs along with their degraded products but phycoremediation has the advantage over these technologies by biodegrading the pollutants without developing resistant genes. Even though phycoremediation has many advantages, industries have found difficulty in adapting this technology as a single-stage treatment process. To overcome these drawbacks recent research studies have focused on developing technology that integrated phycoremediation with the commonly employed treatment processes that are in operation for treating the PPCPs effectively. This review paper focuses on such research approaches that focused on integrating phycoremediation with other technologies such as activated sludge process (ASP), advanced oxidation process (AOP), Up-flow anaerobic sludge blanket reactor (UASBR), UV irradiation, and constructed wetland (CW) with the advantages and limitations of each integration processes. Furthermore, augmenting phycoremediation by co-metabolic mechanism with the addition of sodium chloride, sodium acetate, and glucose for the removal of PPCPs has been highlighted in this review paper.

Metabolism of non-steroidal anti-inflammatory drugs by non-target wild-living organisms

The presence of the non-steroidal anti-inflammatory drugs (NSAIDs) in the environment is a fact, and aquatic and soil organisms are chronically exposed to trace levels of these emerging pollutants. This review presents the current state of knowledge on the metabolic pathways of NSAIDs in organisms at various levels of biological organisation. More than 150 publications dealing with target or non-target analysis of selected NSAIDs (mainly diclofenac, ibuprofen, and naproxen) were collected. The metabolites of phase I and phase II are presented. The similarity of NSAIDs metabolism to that in mammals was observed in bacteria, microalgae, fungi, higher plants, invertebrates, and vertebrates. The differences, such as newly detected metabolites, the extracellular metabolism observed in bacteria and fungi, or phase III metabolism in plants, are highlighted. Metabolites detected in plants (conjugates with sugars and amino acids) but not found in any other organisms are described. Selected, in-depth studies with isolated bacterial strains showed the possibility of transforming NSAIDs into assimilable carbon sources. It has been found that some of the metabolites show higher toxicity than their parent forms. The presence of metabolites of NSAIDs in the environment is the cumulative effect of their introduction with wastewaters, their formation in wastewater treatment plants, and their transformation by non-target wild-living organisms.

Algae-mediated processes for the treatment of antiretroviral drugs in wastewater: Prospects and challenges

The prevalence of pharmaceuticals (PCs), especially antiretroviral (ARV) drugs in various aquatic ecosystems has been expansively reported, wherein wastewater treatment plants (WWTPs) are identified as the primary point source. Consequently, the occurrence, ecotoxicity and treatment of ARV drugs in WWTPs have drawn much attention in recent years. Numerous studies have shown that the widely employed activated sludge-based WWTPs are incapable of removing ARV drugs efficiently from wastewater. Recently, algae-based wastewater treatment processes have shown promising results in PCs removal from wastewater, either completely or partially, through different processes such as biosorption, bioaccumulation, and intra-/inter-cellular degradation. Algal species have also shown to tolerate high concentrations of ARV drugs than the reported concentrations in the environmental matrices. In this review, emphasis has been given on discussing the current status of the occurrence of ARV drugs in the aquatic environment and WWTPs. Besides, the current trends and future perspectives of PCs removal by algae are critically reviewed and discussed. The potential pathways and mechanisms of ARV drugs removal by algae have also been discussed.

Capabilities and mechanisms of microalgae on removing micropollutants from wastewater: A review

Micropollutants in wastewater are a set of compounds receiving a growing concern to the environment and human health. As a green and low-cost process, microalgae-based systems (MBSs) have already been demonstrated the ability of micropollutant removal. In the present review, 114 micropollutants and 16 microalgae species in total are summarized and analyzed to present an overview capability of the MBSs. The analysis shows that MBSs can eradicate most of the included micropollutants with 94 compounds (82% of total) being removed by ≥ 50%. Regarding the reliability of removal efficiency, those from hormone active substances, macrolides, and cephalosporins are consistently removed at a high level (≥80%). Herein, biodegradation is the predominant removal pathway for most micropollutants, particularly, bearing electron-donating groups. Besides, the large family of microalgae species and unique phototrophic ability enables broad ecological niches and extra abilities over activated sludge systems to remove some recalcitrant micropollutants, e.g. pesticides. In the future study, optimization on the reactor configuration and operation parameters is expected to improve the stability of MBSs before extrapolating to full-scale deployment.

Characterization, optimization and kinetics study of acetaminophen degradation by Bacillus drentensis strain S1 and waste water degradation analysis

Background

In this study, the biodegradation of N-acetyl-para-aminophenol also known as acetaminophen (APAP, paracetamol) was studied by bacterial strain Bacillus drentensis strain S1 (accession no. KY623719) isolated from sewage sample.

Results

The Bacillus drentensis strain S1 was isolated from the sewage sample using the enrichment culture method. As per our knowledge this is the first Bacillus drentensis strain reported for the degradation of APAP. In this study a 20-L batch reactor was employed for degradation of APAP. The maximum specific growth rate (μmax) was observed at 400 mg/L concentration of APAP. The pilot-scale anaerobic batch reactor of was stable and self-buffered. The degradation in pilot-scale reactor was slow as compared to batch experiments due to fluctuation in pH and exhaustion of nutrients. Design-Expert® software was used for optimization of conditions for APAP degradation; such as temperature (40 °C), pH (7.0), concentration of APAP (300 g/L) and agitation speed (165 rpm). The FTIR and GC–MS were used to identify the degradation metabolites. The intermediates of degradation like 2-isopropyl-5-methylcyclohexanone and phenothiazine were observed, based on these results the metabolic pathway has been predicted.

Conclusions

The optimization, kinetic, batch study and pilot study indicates the potential of Bacillus drentensis strain S1 for degradation of acetaminophen. The experimental design, optimization and statistical analysis were performed by Design Expert® software. The optimal growth condition for Bacillus drentensis strain S1 was found to be at temperature 40 °C, pH 7, acetaminophen at concentration of 300 (mg/L) and agitation speed 165 rpm. The GC–MS and FTIR was used for identification of metabolites produced during acetaminophen degradation and the partial metabolic pathway for degradation of acetaminophen was also proposed .

A critical review on designs and applications of microalgae-based photobioreactors for pollutants treatment

The development of the photobioreactors (PBs) is recently noticeable as cutting-edge technology while the correlation of PBs' engineered elements such as modellings, configurations, biomass yields, operating conditions and pollutants removal efficiency still remains complex and unclear. A systematic understanding of PBs is therefore essential. This critical review study is to: (1) describe the modelling approaches and differentiate the outcomes; (2) review and update the novel technical issues of PBs' types; (3) study microalgae growth and control determined by PBs types with comparison made; (4) progress and compare the efficiencies of contaminants removal given by PBs' types and (5) identify the future perspectives of PBs. It is found that Monod model's shortcoming in internal substrate utilization is well fixed by modified Droop model. The corroborated data also remarks an array of PBs' types consisting of flat plate, column, tubular, soft-frame and hybrid configuration in which soft-frame and hybrid are the latest versions with higher flexibility, performance and smaller foot-print. Flat plate PBs is observed with biomass yield being 5 to 20 times higher than other PBs types while soft-frame and membrane PBs can also remove pharmaceutical and personal care products (PPCPs) up to 100%. Looking at an opportunity for PBs in sustainable development, the flat plate PBs are applicable in PB-based architectures and infrastructures indicating an encouraging revenue-raising potential.